Comparison of 1.1 gbq and 2.2 gbq131I activities in patients with low-risk differentiated thyroid cancer requiring postoperative iodine-131 therapy.

被引：0
|
作者：
Campenni, A. [1 ]
Ruggeri, R. [1 ]
Garo, M. [2 ]
Raffa, A. [1 ]
Siracusa, M. [1 ]
Restuccia, G. [1 ]
Rappazzo, A. [1 ]
Rosarno, H. [1 ]
Nicocia, A. [1 ]
Cardile, D. [1 ]
Ovcaricek, P. Petranovic [3 ]
Baldari, S. [1 ]
Giovanella, L. [4 ,5 ]
机构：
[1] Osped Gaetano Martino, Messina, Italy
[2] Mathsly Res, Rome, Italy
[3] Univ Hosp Ctr Sestre Milosrdnice, Zagreb 10000, Croatia
[4] Ente Osped Cantonale, Clin Nucl Med, CH-6500 Bellinzona, Switzerland
[5] Ente Osped Cantonale, Imaging Inst Southern Switzerland, Competence Ctr Thyroid Dis, CH-6500 Bellinzona, Switzerland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-392
引用
收藏
页码：S171 / S172
页数：2
相关论文
共 50 条
  • [1] Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study
    Campenni, Alfredo
    Ruggeri, Rosaria Maddalena
    Garo, Maria Luisa
    Siracusa, Massimiliano
    Restuccia, Giovanna
    Rappazzo, Andrea
    Rosarno, Helena
    Nicocia, Antonio
    Cardile, Davide
    Ovcaricek, Petra Petranovic
    Baldari, Sergio
    Giovanella, Luca
    CANCERS, 2023, 15 (09)
  • [2] Thyroid lobe ablation with iodine-131 in patients with differentiated thyroid carcinoma: a randomized comparison between 1.1 and 3.7 GBq activities
    Giovanella, Luca
    Piccardo, Arnoldo
    Paone, Gaetano
    Foppiani, Luca
    Treglia, Giorgio
    Ceriani, Luca
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (08) : 767 - 770
  • [3] Recombinant Human Thyroid Stimulating Hormone in Thyroid Remnant Ablation With 1.1 GBq 131Iodine in Low-Risk Patients
    Rosario, Pedro Weslley
    Malard Xavier, Arthur Cezar
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 101 - 104
  • [4] Thyroid Ablation with 1.1GBq (30 mCi) Iodine-131 in Patients with Papillary Thyroid Carcinoma at Intermediate Risk for Recurrence
    Rosario, Pedro Weslley
    Calsolari, Maria Regina
    THYROID, 2014, 24 (05) : 826 - 831
  • [5] Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer
    Caglar, Meltem
    Bozkurt, Fani M.
    Akca, Ceren Kapulu
    Vargol, Sezen Elhan
    Bayraktar, Miyase
    Ugur, Omer
    Karaagaoglu, Ergun
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (03) : 268 - 274
  • [6] Outcome of ablation of thyroid remnants with 100 mCi (3.7 GBq) iodine-131 in patients with thyroid cancer
    Rosário, PWS
    Barroso, AL
    Rezende, LL
    Padrao, EL
    Fagundes, TA
    Reis, JS
    Purisch, S
    ANNALS OF NUCLEAR MEDICINE, 2005, 19 (03) : 247 - 250
  • [7] Thyroid ablation with 1.1GBq (30mCi) iodine-131 with patients with papillary thyroid carcinoma at intermediate risk for recurrence
    Bez, I. H.
    Somai, M.
    Bennour, S.
    Slim, I.
    Ben Slimene, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S788 - S789
  • [8] Outcome of ablation of thyroid remnants with 100 mCi (3.7 GBq) iodine-131 in patients with thyroid cancer
    Pedro W. S. Rosário
    Álvaro L. Barroso
    Leonardo L. Rezende
    Eduardo L. Padrão
    Tales A. Fagundes
    Janice S. Reis
    Saulo Purisch
    Annals of Nuclear Medicine, 2005, 19 : 247 - 250
  • [9] Therapeutical Dose to Thyroid Remnants Determination for Low-risk Thyroid Carcinoma Patient Treated with rhTSH and 1.1 GBq 131I
    Solny, P.
    Kracmerova, T.
    Jonasova, L.
    Vlcek, P.
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S97 - S97
  • [10] Does remnants from low-risk differentiated thyroid cancer patients really be not treated with Iodine-131?
    Barbato, F.
    Capacchione, D.
    Nappi, A.
    Telesca, D.
    Tempone, A.
    Casolino, E.
    Nardelli, A.
    Castaldi, E.
    Ortosecco, G.
    Storto, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S321 - S321
12345